openPR Logo
Press release

Multiplex Assay Market: Forecast Trend Analysis 2024-2032

04-26-2024 12:11 PM CET | Health & Medicine

Press release from: Triton Market Research

MULTIPLEX ASSAY MARKET

MULTIPLEX ASSAY MARKET

As per Triton's report, the global multiplex assay market is predicted to advance at a CAGR of 8.56% over the forecast years 2024-2032.

A recent study by Triton Market Research titled the Global Multiplex Assay Market report is segmented into Application (Clinical Diagnostics, Research and Development, Companion Diagnostics), Industry Vertical (Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical Laboratories, Hospitals), Technology (Multiplex PCR, Multiplex Protein Microarray, Other Technologies), Product and Service (Instruments and Accessories, Reagents and Consumables, Software and Services), Type (Nucleic Acid-Based Multiplex Assay, Protein-Based Multiplex Assay, Other Multiplex Assays), and Regional Outlook Asia-Pacific, Latin America, (North America, Europe, Middle East and Africa).

Read the Market Summary Here: https://www.tritonmarketresearch.com/reports/multiplex-assay-market?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=TritonPR

A multiplex assay is a method that allows for the simultaneous detection and quantification of multiple analytes, such as proteins, biomolecules, growth factors, and cytokines. It improves analytical efficiency by amplifying numerous targets within a polymerase chain reaction (PCR).

Based on Triton's estimates, the global multiplex assay market is anticipated to witness progress at a CAGR of 8.56% during the forecast period 2024-2032, garnering revenue worth $8235.49 million by 2032.

Request a Free Sample of the Global Multiplex Assay Market Report: https://www.tritonmarketresearch.com/reports/multiplex-assay-market#request-free-sample

The market's growth is fueled by the adoption of personalized medicines, high adoption over traditional methods, and the increasing prevalence of chronic diseases. Conventional assays are characterized by their time-consuming nature and their restriction to analyzing just one assay per cycle. Consequently, there has been a significant shift towards the adoption of multiplex assays, which offer enhanced efficiency and increased output volume while lowering operational costs. This trend is expected to persist as multiplex assays gain preference over their conventional counterparts.

However, challenges in achieving adequate assay range and a lack of skilled workforce negatively impact the multiplex assay market's expansion.

North America leads the multiplex assay market globally. The regional market is experiencing growth driven by increased research and development efforts focused on novel drugs, diagnostics, and treatments, alongside a rising incidence of chronic illnesses like cancer and strokes. Government funding for biomarker detection is another significant factor propelling overall market expansion.

The notable companies in the multiplex assay market comprise Abcam Limited, Agilent Technologies Inc, Becton, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Randox Laboratories Ltd, Dickinson and Company, Bio-Techne Corporation, F Hoffmann-la Roche Ltd, Merck Millipore, Olink Proteomics AB, Illumina Inc, Seegene Inc, Qiagen NV, and Siemens Healthineers AG.

Purchase this report: https://www.tritonmarketresearch.com/reports/multiplex-assay-market#purchase-option

Question & Answer: Global Multiplex Assay Market

Question 1: What factors fuel the multiplex assay market's progression?
Answer: The market's growth is fueled by the adoption of personalized medicines, high adoption over traditional methods, and the increasing prevalence of chronic diseases. Conventional assays are characterized by their time-consuming nature and their restriction to analyzing just one assay per cycle. Consequently, there has been a significant shift towards the adoption of multiplex assays, which offer enhanced efficiency and increased output volume while lowering operational costs. This trend is expected to persist as multiplex assays gain preference over their conventional counterparts.

Question 2: What factors negatively impact the multiplex assay market's expansion?
Answer: Challenges in achieving adequate assay range and a lack of skilled workforce negatively impact the multiplex assay market's expansion.

Question 3: Which region leads the multiplex assay market?
Answer: North America leads the multiplex assay market globally. The regional market is experiencing growth driven by increased research and development efforts focused on novel drugs, diagnostics, and treatments, alongside a rising incidence of chronic illnesses like cancer and strokes. Government funding for biomarker detection is another significant factor propelling overall market expansion.

Question 4: Which are the notable companies in the multiplex assay market?
Answer: The notable companies in the multiplex assay market comprise Abcam Limited, Agilent Technologies Inc, Becton, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Randox Laboratories Ltd, Dickinson and Company, Bio-Techne Corporation, F Hoffmann-la Roche Ltd, Merck Millipore, Olink Proteomics AB, Illumina Inc, Seegene Inc, Qiagen NV, and Siemens Healthineers AG.

Related Reports:

GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET:
https://www.tritonmarketresearch.com/reports/bioengineered-protein-drugs-market

As per Triton's report, the global bioengineered protein drugs market is projected to register revenue growth at a CAGR of 7.7% during 2023-2030.

Varied factors, including increasing incidence of chronic conditions, minimum side effects, and target drug delivery methods, fuel the market's growth. However, the market faces challenges such as high costs associated with these drugs and complications during treatments.

GLOBAL COMPANION DIAGNOSTICS MARKET:
https://www.tritonmarketresearch.com/reports/companion-diagnostics-market

Triton's research report insinuates the global companion diagnostics market to progress at a CAGR of 12.84% during 2022-2028.

The studied market's growth is augmented by factors such as increased medication reactions, prevalence of cancer cases, and rising prevalence of precision medications. On the contrary, a weak reimbursement framework and common cases of leakage in oncology companion diagnostics limit the market's growth.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

Triton is a leading market research company providing clients with the best online market research data reports.Our offerings include syndicated market insights, customized research reports, and cost-effective consulting services for constructive decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiplex Assay Market: Forecast Trend Analysis 2024-2032 here

News-ID: 3477613 • Views:

More Releases from Triton Market Research

Europe Thermometer Market Size,Growth & Industry Report by 2030
Europe Thermometer Market Size,Growth & Industry Report by 2030
Triton Market Research states that the Europe Thermometer Market comprises countries such as Spain, Italy, France, Germany, the United Kingdom, and the Rest of Europe. Key players in this market include Beurer GmbH, Exergen Corporation, Briggs Healthcare, and Omron Healthcare Inc., driving a projected Compound Annual Growth Rate (CAGR) of 8.54% in revenue from 2023 to 2030. Read the Market Summary Here: https://www.tritonmarketresearch.com/reports/europe-thermometer-market#report-overview?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=TritonPR The rising need for thermometers, particularly in the
Middle East and Africa Pharmaceutical Supply Chain Management Market Analysis by 2030
Middle East and Africa Pharmaceutical Supply Chain Management Market Analysis by …
As per Triton's analysis, the Middle East and Africa Pharmaceutical Supply Chain Management Market is undergoing significant growth, with an expected Compound Annual Growth Rate (CAGR) of 6.20% from 2023 to 2030. Read the Market Summary Here: https://www.tritonmarketresearch.com/reports/middle-east-and-africa-pharmaceutical-supply-chain-management-market#report-overview?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=TritonPR This regional market, including key countries like the United Arab Emirates, Turkey, Saudi Arabia, South Africa, and the rest of the Middle East & Africa, is experiencing expansion due to rising healthcare
Global Delivery Drones Market Analysis for 2024-2032
Global Delivery Drones Market Analysis for 2024-2032
According to Triton's research report, the global delivery drones market generated $XX million in 2023 and is expected to generate a CAGR of 40.87% in revenue over the forecasting years 2024-2032. A recent study by Triton Market Research titled Global Delivery Drones Market includes the Global Analysis and Forecasts by Type (Fixed Wing, Multi-Rotor Wing, Hybrid Wing), Component (Hardware, Software, Services), Application (Retail & E-commerce, Logistics & Transportation, Agriculture, Healthcare, Food
Asia-Pacific Thermometer Market Growth Analysis 2023-2030
Asia-Pacific Thermometer Market Growth Analysis 2023-2030
As per Triton's analysis, the Asia-Pacific Thermometer Market encompasses a diverse region including China, South Korea, ASEAN Countries, India, Japan, Australia & New Zealand, and the Rest of Asia-Pacific. With major players like Beurer GmbH, Exergen Corporation, Briggs Healthcare, and Omron Healthcare Inc., this market is witnessing significant growth, projected at a Compound Annual Growth Rate (CAGR) of 8.54% in revenue from 2023 to 2030. Read the Market Summary Here:

All 5 Releases


More Releases for Multiplex

Preference of Multiplex Assays over Conventional Assays Boosts Global Multiplex …
According to a new market research report launched by Inkwood Research, the Global Multiplex Assay Market is estimated to reach around $7922.13 million by 2028, progressing with a CAGR of 8.74% over the forecasting years. Browse 61 market data Tables and 51 Figures spread over 230 Pages, along with in-depth analysis on Global Multiplex Assay Market by Type, End-User, Product, Technology, Application & by Geography. This insightful market research report by Inkwood
Multiplex Assays Market Future Adoption Overview 2028
Multiplex Assays Market: Snapshot The global multiplex assays market has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about the
Multiplex Assays Market Segmented into types, Applications 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assays Market Malleable Strategies in 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assays Market Prominent Growth Rate by 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Biomarker Imaging Market Outlook Report 2027
The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027). Request for TOC @ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc Increased spending on cancer diagnostic and monitoring Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising